Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Lori J. Braender

Aquestive Therapeutics, Inc. reported in an 8-K filed March 20, 2026 that Lori J. Braender resigned as Chief Legal Officer and Chief Compliance Officer, effective April 2, 2026. The proxy statement of Aquestive Therapeutics, Inc. reports total compensation of $1,348,238 for Lori J. Braender in fiscal 2025, including a base salary of $457,962. Disclosed compensation is on record for 4 fiscal years.

“On March 16, 2026, Aquestive Therapeutics, Inc. (the "Company") and Lori J. Braender, Chief Legal Officer, Chief Compliance Officer and Corporate Secretary of the Company, agreed that Ms. Braender will step down from her Chief Legal Officer and Chief Compliance Officer roles and will no longer serve as an executive officer of the Company, effective April 2, 2026.”
Aquestive Therapeutics, Inc. Form 8-K, filed March 20, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Aquestive Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Aquestive Therapeutics, Inc. (AQST) $457,962 $1,348,238
2024 Aquestive Therapeutics, Inc. (AQST) $444,402 $1,821,025
2023 Aquestive Therapeutics, Inc. (AQST) $417,300 $1,146,828
2022 Aquestive Therapeutics, Inc. (AQST) $412,575 $935,910

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.